Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak, et al.
The Lancet (2024) Vol. 403, Iss. 10427, pp. 632-644
Closed Access | Times Cited: 217

Showing 26-50 of 217 citing articles:

Curing Stage IV Melanoma: Where Have We Been and Where Are We?
Pui Ying Chan, Pippa Corrie
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 6
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria
Sofie Meulewaeter, Ilke Aernout, Joke Deprez, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 379-391
Open Access | Times Cited: 6
Give Cas a Chance: An Actionable Path to a Platform for CRISPR Cures
Fyodor D. Urnov
The CRISPR Journal (2024) Vol. 7, Iss. 5, pp. 212-219
Closed Access | Times Cited: 6
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Next-generation cancer vaccines and emerging immunotherapy combinations
Anne Brandenburg, Annkristin Heine, Peter Brossart
Trends in cancer (2024) Vol. 10, Iss. 8, pp. 749-769
Closed Access | Times Cited: 5
Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
Zhongyan Wu, Weilu Sun, Hailong Qi
Vaccines (2024) Vol. 12, Iss. 8, pp. 873-873
Open Access | Times Cited: 5
Advances and applications of RNA vaccines in tumor treatment
Ruohan Yang, Jiuwei Cui
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Advances in Cell and Immune Therapies for Melanoma
Tanase Timis, Sanda Buruiana, Delia Dima, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 98-98
Open Access
Melanoma and Merkel Cell Carcinoma Clinical Trial Status
Taylor P. Williams, Raj G. Vaghjiani, Douglas S. Tyler
Surgical Clinics of North America (2025)
Closed Access
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J. Maine, Shigeki J. Miyake-Stoner, Darina Spasova, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
In-situ trichosanthin-IL2/pectin dynamic hydrogel activates dendritic cells and reverses T cell exhaustion for post-operative cancer therapy
Zeyun Gu, Guihua Chen, Nan Gao, et al.
Chemical Engineering Journal (2025) Vol. 505, pp. 159426-159426
Closed Access
One-pot ligation of multiple mRNA fragments on dsDNA splint advancing regional modification and translation
Yunfan Xu, Shu‐Tao Qi, Gongrui Zhang, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 1
Open Access
Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
Carole Fournier, Marion Mercey-Ressejac, Valentin Dérangère, et al.
EBioMedicine (2025) Vol. 112, pp. 105543-105543
Open Access
Antitumor mRNA vaccines based on neoantigens
Ekaterina V. Starostina, L. F. Nizolenko, Л. И. Карпенко, et al.
Siberian Journal of Oncology (2025) Vol. 23, Iss. 6, pp. 149-158
Open Access
MANEJO ATUAL DO COLANGIOCARCINOMA: ESTADIAMENTO, MORTALIDADE E AVANÇOS TERAPÊUTICOS – UMA REVISÃO DE LITERATURA
Yuri Curcio Chaves, Hélcio Serpa de Figueiredo Júnior
(2025), pp. 217-226
Closed Access
Abordagens e estratégias para a Saúde Pública e Saúde Coletiva 4
José Weverton Almeida‐Bezerra, Lucas Yure Santos da Silva, Severino Denício Gonçalves de Sousa
(2025)
Closed Access
PANORAMA DOS FATORES RELACIONADOS À OCORRÊNCIA DO ÓBITO FETAL: REVISÃO INTEGRATIVA
Vanessa Aparecida Gasparin, Valentina Duffeck, Maria Lúcia Miranda, et al.
(2025), pp. 25-38
Closed Access
BIOTECNOLOGIA E BIOPROSPECÇÃO APLICADOS AO CÂNCER DE PELE: PREVENÇÃO E DESENVOLVIMENTO DE NOVOS PRODUTOS
Helder Freitas dos Santos, Alércio da Silva Soutilha, Natália Guedes Jorge, et al.
(2025), pp. 107-135
Closed Access
ENFERMAGEM E O ENFOQUE NA SEGURANÇA DO PACIENTE
António Figueiredo, Dafne Port Nascimento
(2025), pp. 39-45
Closed Access
A SAÚDE FÍSICA E MENTAL DO SERVIDOR PENITENCIÁRIO COMO FERRAMENTA PARA UMA GESTÃO PRISIONAL EFICIENTE
Elisabete Chaves da Silva Silveira, Elisabeth Müller, Vivian de Souza Cezar, et al.
(2025), pp. 278-286
Closed Access
A GESTÃO PÚBLICA DOS SERVIÇOS DE SAÚDE E SUA RELAÇÃO COM UM HOSPITAL FILANTRÓPICO
Fabiana Rosa Neves Smiderle, Beatriz Pralon Nascimento Castheloge Coutinho, Júlia Mayse Soares Gonçalves, et al.
(2025), pp. 1-24
Closed Access
UMA REVISÃO DE LITERATURA: A INTELIGÊNCIA ARTIFICIAL NO AUXÍLIO DIAGNOSTICO DE ARRITMIAS ATRAVÉS DO ECG
Fernanda Amorim, Gabriela Rodrigues Barbosa, Daniele Cristine Lopes da Silva
(2025), pp. 252-267
Closed Access
ASPECTOS CLÍNICOS DA TROMBOFILIA NA GESTAÇÃO
Francisco Ednaldo Cardoso dos Santos, Aparecida Lívia Ribeiro Santos, Julia Oliveira do Nascimento, et al.
(2025), pp. 239-251
Closed Access
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Helena T. Wu, Van Doren Hsu, Shwe Win, et al.
Visualized Cancer Medicine (2025) Vol. 6, pp. 1-1
Open Access

Scroll to top